Dr. Deepti Behl
Claim this profileCalifornia Pacific Medical Center-Pacific Campus
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
49 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Deepti Behl is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Deepti Behl
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Deepti Behl has experience with
- Pembrolizumab
- Carboplatin
- Atezolizumab
- Durvalumab
- Placebo
- Olaparib
Breakdown of trials Deepti Behl has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepti Behl specialize in?
Deepti Behl focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Deepti Behl currently recruiting for clinical trials?
Yes, Deepti Behl is currently recruiting for 6 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Deepti Behl has studied deeply?
Yes, Deepti Behl has studied treatments such as Pembrolizumab, Carboplatin, Atezolizumab.
What is the best way to schedule an appointment with Deepti Behl?
Apply for one of the trials that Deepti Behl is conducting.
What is the office address of Deepti Behl?
The office of Deepti Behl is located at: California Pacific Medical Center-Pacific Campus, San Francisco, California 94115 United States. This is the address for their practice at the California Pacific Medical Center-Pacific Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.